{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:47:02Z","timestamp":1767134822971,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003245","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000},"record-id":"33712"},{"DOI":"10.1002\/14651858.cd003245.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000},"record-id":"33711"},{"DOI":"10.1002\/14651858.cd003245.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000}}],"reference-count":201,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003245.pub3","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T09:24:37Z","timestamp":1266398677000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease"],"prefix":"10.1002","author":[{"given":"Clare","family":"Donnellan","sequence":"first","affiliation":[{"name":"University of Leeds; Gastroenterology; Room 190A, B Floor Clarendon Wing, LGI Leeds West Yorkshire UK LS1 3EX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Preston","sequence":"additional","affiliation":[{"name":"St James University Hospital; Gastroenterology; Beckett Street Leeds UK LS9 7TF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; Room 4W8E 1200 Main Street West Hamilton Ontario Canada L8N 3Z5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital; Gastroenterology Unit; Edgbaston Birmingham UK B15 2TH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB1|cit1","first-page":"85","article-title":"Comparison between omeprazole and ranitidine in medium-term treatment of reflux oesophagitis","volume":"16","author":"Angelini","year":"1993","journal-title":"Gionale Itialiano Endoscopica Digestica"},{"key":"10.1002\/14651858.CD003245.pub3-BIB2|cit2","first-page":"742","article-title":"Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment","volume":"45","author":"Annibale","year":"1998","journal-title":"Hepato-Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB3|cit3","first-page":"A1494","article-title":"Full dose H2 receptor antagonist prophylaxis does not prevent relapse of reflux oesophagitis","volume":"30","author":"Armstrong","year":"1989","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB4|cit4","first-page":"A55","article-title":"Lansoprazole maintains healing in patients with reflux esophagitis","volume":"110","author":"Baldi","year":"1996","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1572-0241.2002.05666.x","article-title":"Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis","volume":"97","author":"Baldi","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/gut.43.4.458","article-title":"Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10mg or placebo","volume":"43","author":"Bardhan","year":"1998","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/gut.36.4.492","article-title":"Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis","volume":"36","author":"Bate","year":"1995","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2036.1998.00272.x","article-title":"Omeprazole is more effective than cimetidine in the prevention of recurrence of GERD-associated heartburn and the occurrence of underlying oesophagitis","volume":"12","author":"Bate","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD003245.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00042737-200012080-00008","article-title":"Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease","volume":"12","author":"Birbara","year":"2000","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF01316514","article-title":"Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug.","volume":"38","author":"Blum","year":"1993","journal-title":"Digestive Diseases & Sciences"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1111\/j.1572-0241.2000.03179.x","article-title":"Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease","volume":"95","author":"Caos","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD003245.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1365-2036.1998.00379.x","article-title":"Lansoprazole and omeprazole in the prevention of relapse of reflux oesophagitis: a long-term comparative study","volume":"12","author":"Carling","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gut.35.5.590","article-title":"Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety","volume":"35","author":"Dent","year":"1994","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB14|cit14","first-page":"1865","article-title":"Long-Term Maintenance Treatment of Reflux Esophagitis Resistant to H2RA with PPI (Lansoprazol)","volume":"58","author":"Endo","year":"2000","journal-title":"Japanese Journal of Clinical Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1365-2036.1999.00651.x","article-title":"Maintenance therapy with pantoprazole 20mg prevents relapse of reflux oesophagitis","volume":"13","author":"Escourrou","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1572-0241.1999.989_l.x","article-title":"Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.","volume":"94","author":"Festen","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1996.14156000.x","article-title":"Lansoprazole versus ranitidine in the maintenace treatment of reflux oesophagitis","volume":"10","author":"Gough","year":"1996","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0016-5085(94)90531-2","article-title":"Omeprazole or ranitidine in long-term treatment of reflux esophagitis.","volume":"107","author":"Hallerback","year":"1994","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3109\/00365529709002988","article-title":"The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease","volume":"32","author":"Hatlebakk","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2036.1997.144320000.x","article-title":"Lansoprazole 15mg and 30mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis","volume":"11","author":"Hatlebakk","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/1997\/954342","article-title":"Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150mg BID and 300mg BID","volume":"11","author":"Hegarty","year":"1997","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF03022115","article-title":"Prevention of relapse of gastro-oesophagela reflux disease by lansoprazole: 30mg every other day or 15mg daily?","volume":"30","author":"Houcke","year":"2000","journal-title":"Acta Endoscopica"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD003245.pub3-BIB23|cit23","first-page":"A","article-title":"What is the preferred dose of lansoprazole in the maintenance therapy of reflux oesophagitis? The results of a Dutch multi-center comparative trial","volume":"10","author":"Jansen","year":"1998","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1572-0241.2001.03443.x","article-title":"Esomeprazole once daily for 6 months is effective therapy for maintaining healeed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: A randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"96","author":"Johnson","year":"2001","journal-title":"American Journal of Gasroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00365528609034638","article-title":"Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine","volume":"21","author":"Kaul","year":"1986","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2036.1995.tb00382.x","article-title":"Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies","volume":"9","author":"Kimmig","year":"1995","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"A233","DOI":"10.1016\/S0016-5085(03)81169-1","article-title":"Rabeprazole 10mg effectively controls symptoms of gastroesophageal reflux disease (GERD) over 1 year","volume":"124 (4)","author":"Kristensen","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2036.2003.01464.x","article-title":"Esomeprazole 20mg and lansoprazole 15mg in maintaining healed reflux oesophagitis: Metropole study results","volume":"17","author":"Lauritsen","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/00365529109025038","article-title":"Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.","volume":"26","author":"Lundell","year":"1991","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2036.1997.00176.x","article-title":"Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial","volume":"11","author":"McDougall","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2036.2003.01410.x","article-title":"Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis","volume":"17","author":"Metz","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB32|cit32","first-page":"28","article-title":"Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis","volume":"22","author":"Pace","year":"1990","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1365-2036.2003.01593.x","article-title":"Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole","volume":"17","author":"Pilotto","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00042737-200012040-00010","article-title":"Pantoprazole 20mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease","volume":"12","author":"Plein","year":"2000","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"A195","DOI":"10.1016\/0016-5085(95)23441-1","article-title":"Efficacy and safety of lansoprazole 15mg or 30mg OAD as one year maintenance treatment for erosive reflux esophagitis. A randomized trial","volume":"108","author":"Poynard","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"A232","DOI":"10.1016\/S0016-5085(03)81164-2","article-title":"Comparison of the clinical efficacy and safety of pantoprazole versus ranitidine over 3 years to prevent relapse in patients with healed erosive esophagitis","volume":"124","author":"Richter","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.7326\/0003-4819-124-10-199605150-00001","article-title":"Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized double-blind, placebo-controlled trial.","volume":"124","author":"Robinson","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(89)90163-0","article-title":"Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis","volume":"86","author":"Schotborgh","year":"1989","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB39|cit39","first-page":"9","article-title":"Ranitidine in the treatment of symptomatic gastroesophageal reflux disease","volume":"6","author":"Sherbaniuk","year":"1984","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0149-2918(95)80093-X","article-title":"Acid suppression by famotidine 20mg twice daily or 40mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis","volume":"17","author":"Simon","year":"1995","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD003245.pub3-BIB41|cit41","first-page":"1758","article-title":"Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group","volume":"91","author":"Sontag","year":"1996","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.1997.141317000.x","article-title":"Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study","volume":"11","author":"Sontag","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD003245.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/00365529509101589","article-title":"Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.","volume":"30","author":"Staerk-Laursen","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1005548318996","article-title":"Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group.","volume":"45","author":"Thjodleifsson","year":"2000","journal-title":"Digestive Diseases & Sciences"},{"key":"10.1002\/14651858.CD003245.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2036.2003.01446.x","article-title":"A randomized, double-blind trial of the efficacy and safety of 10 or 20mg rabeprazole compared with 20mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years","volume":"17","author":"Thjodleifsson","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/gut.32.11.1280","article-title":"Healing and prevention of relapse of reflux oesophagitis by cisapride","volume":"32","author":"Toussaint","year":"1991","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00365529208999945","article-title":"Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug","volume":"27","author":"Tytgat","year":"1992","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB48|cit48","first-page":"1233","article-title":"Sucralfate maintenance therapy in reflux esophagitis","volume":"90","author":"Tytgat","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2036.2001.01024.x","article-title":"The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month randomised, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"Vakil","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD003245.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/00365529708996509","article-title":"Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice","volume":"32","author":"Venables","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"17","key":"10.1002\/14651858.CD003245.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB52|cit52","first-page":"29","article-title":"Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and refllux esophagitis: A multicentre study","volume":"5 (Suppl)","author":"Anand","year":"1986","journal-title":"Indian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB53|cit53","first-page":"42","article-title":"The treatment of reflux esophagitis with cisapride or H2-antagonist?","volume":"28","author":"Anonymous","year":"1994","journal-title":"Geneesmiddelenbulletin"},{"key":"10.1002\/14651858.CD003245.pub3-BIB54|cit54","first-page":"A16","article-title":"High doses of histamine antagonists do not prevent relapses of peptic esophagitis following therapy with a proton pump inhibitor","volume":"98","author":"Antonson","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB55|cit55","first-page":"67","article-title":"De-Nol in the treatment of reflux esophagitis","volume":"93","author":"Balan","year":"1989","journal-title":"Revista Medico-Chirugicala a Societati de Medici Si Naturalisti Din Iasi"},{"key":"10.1002\/14651858.CD003245.pub3-BIB56|cit56","first-page":"29","article-title":"Long-term treatment of reflux oesophagitis","volume":"22 Supp 2","author":"Baldi","year":"1990","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/gut.31.7.745","article-title":"Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine","volume":"31","author":"Bardhan","year":"1990","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB58|cit58","first-page":"A18","article-title":"Refractory oesophagitis: results of maintenance treatment with high dose H2 receptor antagonist (H2RA) or omeprazole (OM)","volume":"98","author":"Bardhan","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.1995.tb00779.x","article-title":"The role of proton pump inhibitors in the treatment of gastro-oeosphageal reflux disease","volume":"9 Supp 1","author":"Bardhan","year":"1995","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB60|cit60","first-page":"A203","article-title":"Symptomatic gastroesophageal reflux disease (GERD): Intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management","volume":"41 Suppl 3","author":"Bardhan","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.318.7182.502","article-title":"Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European study group.","volume":"318","author":"Bardhan","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003245.pub3-BIB62|cit62","first-page":"A45","article-title":"Symptom relief with omeprazole in patients without unequivocal oesophagitis","volume":"37 Suppl 2","author":"Bate","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2036.1997.00198.x","article-title":"Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis","volume":"11","author":"Bate","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB64|cit64","first-page":"65","article-title":"The effect of metoclopramide on gastro-oesophageal reflux","volume":"49 Supp 4","author":"Bennett","year":"1973","journal-title":"Postgraduate Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB65|cit65","first-page":"1585","article-title":"High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a \"medium-term\" open study","volume":"86","author":"Bianchi-Porro","year":"1991","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1345\/aph.18224","article-title":"The efficacy of extended-interval dosing of omeprazole in keeping gastroesophageal reflux disease patients symptom free","volume":"33","author":"Bieszk","year":"1999","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB67|cit67","first-page":"XXXVII","article-title":"Omeprazole in the treatment of reflux esophagitis","volume":"22","author":"Bigard","year":"1992","journal-title":"Acta Endoscopica"},{"issue":"Supp 3","key":"10.1002\/14651858.CD003245.pub3-BIB68|cit68","first-page":"A202","article-title":"Omeprazole is superior to ranitidine in curing and further managing patients with heartburn","volume":"41","author":"Blom","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJM198603133141116","article-title":"Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis","volume":"314","author":"Blum","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(80)90570-X","article-title":"Two-year follow-up after one year's treatment with cimetidine or placebo","volume":"1","author":"Bodemar","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003245.pub3-BIB71|cit71","first-page":"2449","article-title":"The prevention of recurrence in reflux esophagitis","volume":"48","author":"Bouche","year":"1990","journal-title":"Medecine et Hygiene"},{"key":"10.1002\/14651858.CD003245.pub3-BIB72|cit72","first-page":"81","article-title":"Cimetidine (Tagamet) in oesophageal reflux","volume":"17","author":"Bradby","year":"1980","journal-title":"Clinical Trials Journal"},{"key":"10.1002\/14651858.CD003245.pub3-BIB73|cit73","first-page":"A128","article-title":"Rabeprazole relieves heartburn as rapidly as ranitidine and is more effective","volume":"116","author":"Breiter","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB74|cit74","first-page":"1025","article-title":"Effects of long term maintenance cimetidine therapy on gastroesophageal reflux disease","volume":"82","author":"Bright-Asare","year":"1982","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004836-198006000-00008","article-title":"Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux","volume":"2","author":"Bright-Asare","year":"1980","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5694\/j.1326-5377.1979.tb112743.x","article-title":"Cimetidine in the treatment of reflux esophagitis","volume":"2","author":"Brown","year":"1979","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD003245.pub3-BIB77|cit77","first-page":"440","article-title":"Efficacy of reflux oesophagitis treatment by H2-blockers","volume":"83","author":"Cappelli","year":"1983","journal-title":"Acta Chirurgica Belgica"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB78|cit78","first-page":"61","article-title":"The effect of sustained-release metoclopramide (Prokinyl LP (TM)) on symptomatic gastroesophageal reflux","volume":"20","author":"Cargill","year":"1991","journal-title":"Medecine et Chirurgie Digestives"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole","volume":"10","author":"Carlsson","year":"1998","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"A67","DOI":"10.1016\/0016-5085(95)22930-2","article-title":"Large trial compares lansoprazole to omeprazole","volume":"108","author":"Castell","year":"1995","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF01300388","article-title":"Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion","volume":"37","author":"Collen","year":"1992","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD003245.pub3-BIB82|cit82","first-page":"1128","article-title":"Gastroesophageal reflux after metoclopramide or cimetidine treatment. A randomized double blind study","volume":"80","author":"Corazziari","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB83|cit83","first-page":"A109","article-title":"Pantoprazole is superior to famotidine in the treatment of reflux esophagitis - a multicenter study","volume":"39 Suppl 3","author":"Dammann","year":"1996","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5694\/j.1326-5377.1983.tb122634.x","article-title":"Treatment of reflux oesophagitis","volume":"2","author":"Carle","year":"1983","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD003245.pub3-BIB85|cit85","first-page":"A59","article-title":"Cisapride in the treatment of GERD: a double-blind placebo-controlled multicenter dose-response trial","volume":"102","author":"De","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB86|cit86","first-page":"A56","article-title":"Is lansoprazole 30mg as effective as omeprazole 40mg in the treatment of acute reflux oesopgagitis grade II, III and IV? Results of a Dutch multicenter study","volume":"37 Suppl 2","author":"Dekker","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB87|cit87","first-page":"3512","article-title":"Treatment of reflux esophagitis","volume":"33","author":"Delmont","year":"1983","journal-title":"Therapiewoche"},{"issue":"8","key":"10.1002\/14651858.CD003245.pub3-BIB88|cit88","first-page":"563","article-title":"The effectiveness of Azantac in the treatment of gastroesophageal reflux esophagitis","volume":"17","author":"Delmotte","year":"1988","journal-title":"Medecine et Chirurgie Digestives"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB89|cit89","first-page":"271","article-title":"Sucralfate versus placebo in the treatment of reflux esophagitis. A randomized, double-blind study","volume":"13","author":"Demelia","year":"1990","journal-title":"Giornale Italiano di Endoscopia Digestiva"},{"key":"10.1002\/14651858.CD003245.pub3-BIB90|cit90","article-title":"Omeprazole prevents relapse of peptic oesophagitis","volume":"FP4","author":"Dent","year":"1990","journal-title":"World Congress of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0011-393X(05)80173-0","article-title":"Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study","volume":"55","author":"Mario","year":"1994","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"key":"10.1002\/14651858.CD003245.pub3-BIB92|cit92","first-page":"A126","article-title":"Oral cisapride in GERD: a double blind placebo-controlled multicenter trial","volume":"96","author":"Dodds","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB93|cit93","first-page":"3","article-title":"Reflux esophagitis peptic ulcer duodenal and gastric treatment with ranitidine. Preliminary report of double-blind multi-institutional study","volume":"10","author":"Elizalde","year":"1983","journal-title":"Investigacion Medica Internacional"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB94|cit94","first-page":"93","article-title":"Low-dose omeprazole for erosive esophagitis","volume":"48","author":"Epling","year":"1999","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD003245.pub3-BIB95|cit95","first-page":"133","article-title":"Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis. Results of prospective double-blind randomised clinical trial","volume":"77","author":"Eriksen","year":"1988","journal-title":"Annales Chirurgiae et Gynaecologiae"},{"key":"10.1002\/14651858.CD003245.pub3-BIB96|cit96","first-page":"A56","article-title":"Cisapride in the treatment of GERD: a double-blind placebo-controlled multicenter dose-response trial","volume":"102","author":"Faruqui","year":"1992","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB97|cit97","first-page":"237","article-title":"Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment","volume":"23","author":"Festen","year":"1980","journal-title":"Netherlands Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB98|cit98","first-page":"A34","article-title":"Symptom relief in symptomatic mild reflux oesophagitis: omeprazole 20mg om more effective than high dose ranitidine 300mg bid","volume":"8","author":"Festen","year":"1996","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB99|cit99","first-page":"573","article-title":"Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery","volume":"53","author":"Fiasse","year":"1990","journal-title":"Acta Gastroenterologica Belgica"},{"issue":"11","key":"10.1002\/14651858.CD003245.pub3-BIB100|cit100","first-page":"356","article-title":"Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis","volume":"77","author":"Fielding","year":"1984","journal-title":"Irish Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB101|cit101","first-page":"984","article-title":"Randomized double-blind trial comparing a liquid suspension of alignate to placebo for the treatment of heartburn related to gastroesophageal reflux disease.","volume":"15","author":"Filoche","year":"1991","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD003245.pub3-BIB102|cit102","first-page":"1062","article-title":"A double-blind trial comparing high dose liquid antacid to placebo and cimetidine in improving symptoms and objective parameters in gastroesophageal reflux","volume":"82","author":"Furman","year":"1982","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB103|cit103","first-page":"597","article-title":"Combination sucralfate and histamine2-antagonist therapy","volume":"28","author":"Gales","year":"1994","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD003245.pub3-BIB104|cit104","first-page":"S58","article-title":"Lansoprazole is superior to ranitidine 300mg BD in prevention of relapse of reflux oesophagitis","volume":"35 Suppl 5","author":"Gough","year":"1994","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB105|cit105","first-page":"1073","article-title":"Double-blind comparison of liquid antacid and placebo in reflux esophagitis","volume":"82","author":"Graham","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB106|cit106","first-page":"229","article-title":"Effect of a new formulation of almagate on gastroesophageal reflux in patients with esophagitis. Randomized, single-blind, cross-over study","volume":"83","author":"Grande","year":"1993","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"10.1002\/14651858.CD003245.pub3-BIB107|cit107","first-page":"63","article-title":"Omeprazole 20mg to 40mg once daily is more effective than ranitidine 300mg to 600mg daily in providing complete symptom relief and endoscopic healing in patients with reflux oesophagitis","volume":"6","author":"Green","year":"1995","journal-title":"British Journal of Clinical Research"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB108|cit108","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1365-2036.1997.00246.x","article-title":"Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole","volume":"11","author":"Hatlebakk","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00042737-199705000-00018","article-title":"Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oeosphageal reflux disease","volume":"9","author":"Havelund","year":"1997","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB110|cit110","first-page":"S7","article-title":"Omeprazole versus ranitidine in the treatment of symptomatic mild reflux oesophagitis: a dutch multi-centre trial","volume":"35 Suppl 2","author":"Hazenberg","year":"1994","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000199020","article-title":"Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study","volume":"29","author":"Hine","year":"1984","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD003245.pub3-BIB113|cit113","first-page":"A202","article-title":"15mg lansoprazole daily or 30mg lansoprazole every other day in long term treatment of erosive reflux esophagitis","volume":"41 Suppl 3","author":"Houcke","year":"1997","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004836-198702000-00007","article-title":"Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus","volume":"9","author":"Humphries","year":"1987","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB115|cit115","first-page":"1616","article-title":"Rabeprazole vs omeprazole for maintenance therapy of healed erosive GERD: Results of a 1-year multicenter trial","volume":"93","author":"Humphries","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB116|cit116","first-page":"A63","article-title":"Comparison of 2 dosage regimens of omeprazole - 10mg once daily and 20mg weekends - as prophylaxis against recurrence of reflux oesophagitis","volume":"98","author":"Isal","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB117|cit117","first-page":"67","article-title":"Cisapride versus ranitidine in reflux eophagitis","volume":"28 Supp 1","author":"Janisch","year":"1990","journal-title":"Zeitschrift fur Gastroenterologie"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1365-2036.1999.00656.x","article-title":"Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis","volume":"13","author":"Jansen","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD003245.pub3-BIB119|cit119","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1440-1746.1996.tb00269.x","article-title":"Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease","volume":"11","author":"Jaspersen","year":"1996","journal-title":"Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB120|cit120","first-page":"A157","article-title":"Effect of sucralfate on reflux esophagitis","volume":"10 Suppl 4","author":"Jin","year":"1995","journal-title":"Journal of Gastroenterology & Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB121|cit121","first-page":"159","article-title":"Maintenance therapy in reflux esophagitis","volume":"35","author":"Katsoulis","year":"1997","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD003245.pub3-BIB122|cit122","first-page":"199","article-title":"PPIs vs H2RAs for erosive reflux esophagitis","volume":"46","author":"King","year":"1998","journal-title":"Journal of Family Practice"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB123|cit123","first-page":"161","article-title":"Effect of sucralfate suspension in the treatment of reflux esophagitis","volume":"24","author":"Kishi","year":"1996","journal-title":"Japanese Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000200915","article-title":"Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy","volume":"51 Supp 1","author":"Klinkenberg-Knol","year":"1992","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD003245.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","article-title":"Long-term treatment with omeprazole for refractory reflux oesophagitis: efficacy and safety","volume":"121","author":"Klinkenberg-Knol","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB127|cit127","first-page":"A70","article-title":"Efficacy and safety of long term omeprazole maintenance therapy in H2-blocker-resistant reflux esophagitis healed by omeprazole","volume":"98","author":"Koop","year":"1990","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF01297018","article-title":"Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis","volume":"36","author":"Koop","year":"1991","journal-title":"Digestive Diseases & Sciences"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB129|cit129","first-page":"43","article-title":"Clinical study of reflux esophagitis resistant to H2-receptor antagonists","volume":"26","author":"Kurosawa","year":"1998","journal-title":"Japanese Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB130|cit130","first-page":"43","article-title":"Sucralfate vs. alginate plus antacid in reflux oesophagitis, a randomized, endoscopically controlled, double-blind multicenter study","volume":"86 Suppl","author":"Laitinen","year":"1983","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB131|cit131","first-page":"38","article-title":"Efficacy and tolerance of Algicon in patients with reflux oesophagitis","volume":"43","author":"Lancaster Smith","year":"1989","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003245.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"A145","DOI":"10.1016\/0016-5085(95)23245-1","article-title":"Efficacy of omeprazole 20mg followed by maintenance treatment with omeprazole 10mg for the relief and prophylaxis against recurrence of GERD symptoms in patients with low-grade oesophagitis","volume":"108","author":"Laurent","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB133|cit133","first-page":"17","article-title":"Efficacy of omeprazole 20mg or 10mg in the therapeutics management of simple gastro-oesophageal reflux or complicated by oesophagitis","volume":"34","author":"Laurent","year":"1998","journal-title":"Annales de Gastroenterologie et d'Hepatologie"},{"key":"10.1002\/14651858.CD003245.pub3-BIB134|cit134","first-page":"A109","article-title":"Omeprazole 10mg or 20mg daily for the prevention of relapse in gastroesophageal reflux disease? A double-blind comparative study.","volume":"102","author":"Laursen","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB135|cit135","first-page":"A1501","article-title":"Controlled study of cisapride in the treatment of grade II and III oesophagitis","volume":"92","author":"Lepoutre","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB136|cit136","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000200522","article-title":"Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine","volume":"47 Supp 1","author":"Lundell","year":"1990","journal-title":"Digestion"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB137|cit137","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2036.1997.tb00800.x","article-title":"New information relevant to long-term management of endoscopy-negative reflux disease","volume":"11","author":"Lundell","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB138|cit138","first-page":"73","article-title":"Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1\/2-year period","volume":"65","author":"Markham","year":"1980","journal-title":"Scandinavian Journal of Gastroenterology - Supplement"},{"key":"10.1002\/14651858.CD003245.pub3-BIB139|cit139","first-page":"595","article-title":"Omeprazole in the treatment of reflux oesophagitis","volume":"16","author":"McCarthy","year":"1986","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB140|cit140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1185\/03007999309111544","article-title":"Metoclopramide in the treatment of reflux oesophagitis: a comparison of normal and controlled-release formulations","volume":"13","author":"McLoughlin","year":"1993","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD003245.pub3-BIB141|cit141","first-page":"F23","article-title":"Lansoprazole provides greater symptom relief than omeprazole in reflux oesophagitis","volume":"36 Suppl 1","author":"Mee","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB142|cit142","first-page":"325","article-title":"Clinical evaluation of Z103 on gastritis - a multicenter double-blind comparative study with sucralfate","volume":"25","author":"Miwa","year":"1997","journal-title":"Japanese Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB143|cit143","first-page":"197","article-title":"Ranitidine in the management of gastro-oesophageal reflux disease","volume":"28","author":"Nelis","year":"1985","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB144|cit144","first-page":"787","article-title":"Cimetidine versus ranitidine in the treatment of peptic esophagitis","volume":"74","author":"Noya","year":"1983","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD003245.pub3-BIB145|cit145","first-page":"59","article-title":"Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results","volume":"66","author":"Pace","year":"1989","journal-title":"British Journal of Clinical Practice Supplement"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB146|cit146","first-page":"292","article-title":"Omeprazole maintenance therapy for GERD","volume":"45","author":"Parks","year":"1997","journal-title":"Journal of Family Practice"},{"issue":"17","key":"10.1002\/14651858.CD003245.pub3-BIB147|cit147","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5694\/j.1326-5377.1974.tb71049.x","article-title":"A controlled trial of metoclopramide in reflux oesophagitis","volume":"2","author":"Paull","year":"1974","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD003245.pub3-BIB148|cit148","first-page":"462","article-title":"Lansoprazole versus ranitidine in the treatment of reflux esophagitis. Multicentric study","volume":"20","author":"Petite","year":"1991","journal-title":"Medecine et Chirurgie Digestives"},{"key":"10.1002\/14651858.CD003245.pub3-BIB149|cit149","first-page":"155","article-title":"The effect of metoclopramide on gastro-oesophageal reflux","volume":"20","author":"Pflucke","year":"1977","journal-title":"Tijdschrift voor Gastro-Enterologie"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB150|cit150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s004230000139","article-title":"Results of short- and lon-term medical treatment of gastroeosphageal reflux disease (GERD)","volume":"385","author":"Pohle","year":"2000","journal-title":"Langenbecks Archives of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB151|cit151","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02970326","article-title":"Fate of patients after healing an oeosphagitis. A prospective study of alginate as self-care treatment for 6 months.","volume":"21","author":"Poynard","year":"1991","journal-title":"Acta Endoscopica"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB152|cit152","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.1993.tb00111.x","article-title":"Relapse rate of patients after healing of oesophagitis - a prospective study of alginate as self-care treatment for 6 months. French Co-operative Study Group.","volume":"7","author":"Poynard","year":"1993","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD003245.pub3-BIB153|cit153","first-page":"311","article-title":"Multicentric randomized clinical study on sodium alginate versus cisapride in the treatment of uncomplicated gastroesophageal reflux in general medicine","volume":"25","author":"Poynard","year":"1996","journal-title":"Medecine et Chirurgie Digestives"},{"issue":"2","key":"10.1002\/14651858.CD003245.pub3-BIB154|cit154","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0016-5085(95)90103-5","article-title":"Long-term treatment of erosive esophagitis with omeprazole: does it work?","volume":"108","author":"Rabeneck","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB155|cit155","first-page":"6","article-title":"Treatment of peptic esophagitis with cimetidine","volume":"133 Supp 1","author":"Ramirez-Degollado","year":"1977","journal-title":"Gaceta Medica de Mexico"},{"key":"10.1002\/14651858.CD003245.pub3-BIB156|cit156","first-page":"A166","article-title":"Lansoprazole for one year prevents recurrence of erosive reflux oesophagitis","volume":"106","author":"Robinson","year":"1994","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB157|cit157","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1001\/archinte.1991.00400120040007","article-title":"Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations: results of a multicenter, placebo-controlled, dose-ranging study","volume":"151","author":"Sabesin","year":"1991","journal-title":"Archieves of Internal Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB158|cit158","first-page":"1267","article-title":"A double blind controlled trial of bethanechol plus antacids vs. placebo plus antacids for the treatment of erosive esophagitis","volume":"80","author":"Saco","year":"1981","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD003245.pub3-BIB159|cit159","first-page":"327","article-title":"Effect of omeprazole on reflux esophagitis","volume":"23","author":"Sato","year":"1995","journal-title":"Japanese Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD003245.pub3-BIB160|cit160","first-page":"152","article-title":"Reflux oesophagitis. Comparison of the efficacy of sucralfate and ranitidine","volume":"130","author":"Simon","year":"1988","journal-title":"Munchener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD003245.pub3-BIB161|cit161","first-page":"1107","article-title":"Ranitidine in the treatment of gastroesophageal reflux disease","volume":"64","author":"Sontag","year":"1988","journal-title":"Zeitschrift fur Allgemeinmedizin"},{"key":"10.1002\/14651858.CD003245.pub3-BIB162|cit162","first-page":"A1258","article-title":"Daily omeprazole is needed to maintain healing","volume":"87","author":"Sontag","year":"1992","journal-title":"American Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB163|cit163","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJM199203193261202","article-title":"Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group","volume":"326","author":"Spechler","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB164|cit164","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2036.2001.00943.x","article-title":"Esomeprazole 20mg maintains symptom control in endoscopy negative gastro-oeosphageal reflux disease: a controlled trial of on-demand therapy for 6 months","volume":"15","author":"Talley","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB165|cit165","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1136\/bmj.286.6381.1863","article-title":"Cimetidine and metoclopramide in oeosphageal reflux disease","volume":"286","author":"Temple","year":"1983","journal-title":"British Medical Journal Clinical Research Ed"},{"key":"10.1002\/14651858.CD003245.pub3-BIB166|cit166","first-page":"51B","article-title":"Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms","volume":"11 Supp B","author":"Tougas","year":"1997","journal-title":"Canadian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB167|cit167","first-page":"2432","article-title":"Recurrence of reflux oesophagitis preventable with sucralfate maintenance treatment","volume":"139","author":"Tytgat","year":"1995","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD003245.pub3-BIB168|cit168","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM199510263331711","article-title":"Long term therapy for reflux oesophagitis","volume":"333","author":"Tytgat","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003245.pub3-BIB169|cit169","first-page":"A542","article-title":"Esomeprazole provides more effective maintenance therapy following healing of erosive esophagitis in patients with dysphagia at baseline compared with lansoprazole","volume":"124","author":"Vakil","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB170|cit170","first-page":"716","article-title":"Effect of domperidone on patients with symptomatic gastroesophageal reflux","volume":"25","author":"Valenzuela","year":"1980","journal-title":"Digestive Diseases & Sciences"},{"key":"10.1002\/14651858.CD003245.pub3-BIB171|cit171","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1365-2036.1999.00573.x","article-title":"Safety and efficacy of pantoprazole 40mg daily as relapse prophylaxis in patients with healed reflux oesophagitis - a 2-year follow-up","volume":"13","author":"Rensburg","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB172|cit172","first-page":"73","article-title":"A double-blind study of metoclopramide in symptomatic peptic oesophagitis","volume":"49 Suppl 4","author":"Venables","year":"1973","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD003245.pub3-BIB173|cit173","first-page":"A17","article-title":"Long-term maintenance therapy with sucralfate in patients with mild erosive reflux esophagitis","volume":"37 Suppl 2","author":"Vosmaer","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB174|cit174","first-page":"52","article-title":"Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux","volume":"43","author":"Ward","year":"1989","journal-title":"British Journal of Clinical Practice"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD003245.pub3-BIB175|cit175","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0016-5085(78)90133-6","article-title":"Oral cimetidine in reflux esophagitis: a double blind controlled trial","volume":"74","author":"Wesdorp","year":"1978","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD003245.pub3-BIB176|cit176","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/BF01299910","article-title":"Efficacy of famotidine 20mg twice a day versus 40mg twice a day in the treatment of erosive or ulcerative reflux esophagitis","volume":"38","author":"Wesdorp","year":"1993","journal-title":"Digestive Diseases & Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003245.pub3-BIB177|cit177","first-page":"19","article-title":"Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group","volume":"30","author":"Wiklund","year":"1998","journal-title":"Italian Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB178|cit178","first-page":"1292","article-title":"Double-blind trial of metoclopramide versus placebo-antacid in symptomatic gastroesophageal reflux","volume":"78","author":"Winnan","year":"1980","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1002\/14651858.CD003245.pub3-BIB179|cit179","first-page":"1077","article-title":"Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)","volume":"139","author":"Wittman","year":"1998","journal-title":"Orvosi Hetilap"},{"key":"10.1002\/14651858.CD003245.pub3-BIB180|cit180","first-page":"621","article-title":"Omeprazole versus ranitidine in erosive oesophagitis","volume":"67","author":"Zeitoun","year":"1987","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD003245.pub3-BIB181|cit181","first-page":"1025","article-title":"Effects of long term maintenance cimetidine (CIM) therapy on gastroesophageal reflux disease (GERD)","volume":"82","author":"Bright-Asare","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB182|cit182","first-page":"A201","article-title":"Comparison of omeprazole 10mg and ranitidine 150mg bid in the long term treatment of reflux oesophagitis","volume":"41 Suppl 3","author":"Festen","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB183|cit183","first-page":"A201","article-title":"Long-term (3 years) prevention of relapse of mild and moderate esophagitis with omeprazole and cispride","volume":"41 Suppl 3","author":"Kimmig","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB184|cit184","first-page":"A148","article-title":"Lansoprazole vs omeprazole in reflux esophagitis: Clinical evaluation at one year","volume":"29 Suppl 2","author":"Signorelli","year":"1997","journal-title":"Italian Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB185|cit185","first-page":"1595","article-title":"Ranitidine versus placebo in long-term treatment of gastroesophageal reflux (GERD)","volume":"88","author":"Sontag","year":"1988","journal-title":"Gastroenterology"},{"issue":"2-3","key":"10.1002\/14651858.CD003245.pub3-BIB186|cit186","first-page":"93","article-title":"Endoscopic evaluation of Gastroesophageal reflux disease (review)","volume":"72","author":"Armstrong","year":"1999","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003245.pub3-BIB187|cit187","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0149-2918(01)80087-4","article-title":"Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole and pantoprazole compared with omeprazole, ranitidine and placebo: evidence from randomized clinical trials","volume":"23","author":"Caro","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD003245.pub3-BIB188|cit188","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in Grade 2 to 4 Gastroesophageal reflux disease: A Meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"issue":"suppl 2","key":"10.1002\/14651858.CD003245.pub3-BIB189|cit189","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gut.44.2008.S1","article-title":"An evidence-based appraisal of reflux disease management - the Genval Workshop Report","volume":"44","author":"Dent","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB190|cit190","doi-asserted-by":"crossref","first-page":"s17","DOI":"10.1016\/S0002-9270(99)00658-9","article-title":"Treatment advances in acid secretory disorders: the promise of rapid symptom relief with disease resolution (review)","volume":"94","author":"Earnest","year":"1999","journal-title":"American Review of Gastroenterology"},{"key":"10.1002\/14651858.CD003245.pub3-BIB191|cit191","first-page":"165","article-title":"Systematic review of proton pump inhibitors for the maintenance of healed relfux oesophagitis","volume":"5","author":"Edwards","year":"2002","journal-title":"Journal of Drug Assessment"},{"issue":"4","key":"10.1002\/14651858.CD003245.pub3-BIB192|cit192","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1996.14156000.x","article-title":"Lansoprazole versus ranitidine in the maintenace treatment of reflux oesophagitis","volume":"10","author":"Gough","year":"1996","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB193|cit193","first-page":"9","article-title":"Preventing GORD relapse: the evidence","volume":"5","author":"Holt","year":"2001","journal-title":"International Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD003245.pub3-BIB194|cit194","first-page":"646","article-title":"GORD - the disease of the millennium","volume":"59","author":"Navaratham","year":"1998","journal-title":"Hospital Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB195|cit195","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/gut.44.5.598","article-title":"Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity","volume":"44","author":"Nehra","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003245.pub3-BIB196|cit196","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0016-5085(98)70010-1","article-title":"Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects","volume":"115","author":"Peghini PL. Katz PO. Castell","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD003245.pub3-BIB197|cit197","first-page":"1161","article-title":"Gastroesophageal reflux disease, diagnosis and management","volume":"59","author":"Scott","year":"1999","journal-title":"American Family Physician"},{"issue":"iv","key":"10.1002\/14651858.CD003245.pub3-BIB198|cit198","first-page":"58","article-title":"A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials","volume":"53","author":"Sharma","year":"2004","journal-title":"Gut"},{"issue":"2-3","key":"10.1002\/14651858.CD003245.pub3-BIB199|cit199","first-page":"81","article-title":"Clinical epidemiology and natural history of gastroesophageal reflux disease","volume":"72","author":"Sonnenberg","year":"1999","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003245.pub3-BIB200|cit200","article-title":"Short-term treatment with PPIs, H2RAs and prokinetics for GORD-like symptoms and ENRD","author":"Pinxteren","year":"2000","journal-title":"The Cochrane Library"},{"issue":"suppl 4","key":"10.1002\/14651858.CD003245.pub3-BIB201|cit201","first-page":"22s","article-title":"Gastroesophageal reflux disease","volume":"92","author":"Williams","year":"1997","journal-title":"Canadian Journal of Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003245.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T23:00:21Z","timestamp":1711234821000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003245.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":201,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003245.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}